Investigations in several different tumour types have revealed increased IGF activity in chemoresistant tumours and shown that IGF1R inhibition acts as a chemosensitizer (Dallas et al., 2009; Eckstein et al., 2009; Juan et al., 2011; Ireland et al., 2016; Cao et al., 2017). Here, IGF1R is linked to neoplasm.